Daiwa Securities Group
ACOR

Daiwa Securities Group’s Acorda Therapeutics ACOR Stock Holding History

Daiwa Securities Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2
Closed -$1K – 1259
2019
Q3 		$1K Hold
2
– – ﹤0.01% 1166
2019
Q2 		$2K Hold
2
– – ﹤0.01% 1161
2019
Q1 		$3K Hold
2
– – ﹤0.01% 1116
2018
Q4 		$4K Hold
2
– – ﹤0.01% 1079
2018
Q3 		$5K Hold
2
– – ﹤0.01% 1085
2018
Q2 		$7K Hold
2
– – ﹤0.01% 1079
2018
Q1 		$6K Buy
+2
New +$5.99K ﹤0.01% 1068

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Daiwa Securities Group's ACOR Position: Q4 2019 in Review

Daiwa Securities Group sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 2 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in ACOR in Q1 2018 and held it in 7 quarters. The position peaked at $7K in Q2 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Daiwa Securities Group reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 2 Acorda Therapeutics shares in Q4 2019, an estimated $1K.
  • Daiwa Securities Group first reported a position in Acorda Therapeutics in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Acorda Therapeutics position peaked at $7K in Q2 2018.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.